Investment 17 February 2026 - 18 February 2026

POLE Stock Is Quiet. Andretti Acquisition II’s September Deadline Is Not

POLE Stock Is Quiet. Andretti Acquisition II’s September Deadline Is Not

Andretti Acquisition Corp. II’s Class A shares (POLE) closed at $10.71 on Thursday, down 0.3% with just 3,504 shares traded. The company, a SPAC, faces a Sept. 9 deadline to complete a business combination or risk liquidation, with filings citing “substantial doubt” about its ability to continue. Its planned merger with StoreDot was terminated in February. Andretti reported $246.4 million in its trust account as of March 31.
May 28, 2026
Bitcoin price slides near $66,000 after Fed minutes; ETF outflows and inflation data in focus

Bitcoin price slides near $66,000 after Fed minutes; ETF outflows and inflation data in focus

Bitcoin dropped 2% to $66,301 in late New York trade Wednesday, while Ether fell 2.6% to $1,943. Minutes from the Federal Reserve’s January meeting showed officials divided on future rate hikes, keeping the benchmark rate at 3.50%-3.75%. U.S.-listed spot bitcoin ETFs saw $8.5 billion in outflows since October, according to Bloomberg. Crypto-related U.S. stocks were mixed after hours.
February 18, 2026
Gold price jumps 2% back toward $5,000 as geopolitics, Fed minutes jolt bullion

Gold price jumps 2% back toward $5,000 as geopolitics, Fed minutes jolt bullion

Gold prices jumped 2.4% to $4,992.11 an ounce Wednesday after peace talks between Ukraine and Russia stalled and U.S.-Iran negotiations showed little progress. The rebound followed a sharp drop Tuesday, when spot gold hit a one-week low. U.S. April futures settled at $5,009.50. Investors await Friday’s U.S. PCE inflation data for clues on Federal Reserve policy.
February 18, 2026
Robinhood stock edges up as HOOD pitches $1 billion venture-fund IPO and free tax filing

Robinhood stock edges up as HOOD pitches $1 billion venture-fund IPO and free tax filing

Robinhood shares rose 0.6% to $75.90 after launching a roadshow for its first closed-end venture fund aimed at retail investors, with plans to list 40 million shares at $25 each on the NYSE under “RVI.” The company also announced free tax filing for eligible customers through a partnership with april. Coinbase was little changed, while Schwab and Interactive Brokers gained over 2% as bitcoin fell 2%.
February 18, 2026
Mortgage rates today near 6% as refi demand rebounds; housing stocks steady ahead of Fed minutes

Mortgage rates today near 6% as refi demand rebounds; housing stocks steady ahead of Fed minutes

Refinancing applications jumped 7% last week as the average 30-year fixed mortgage rate fell to 6.17%, according to the Mortgage Bankers Association. Total mortgage applications rose 2.8%, while purchase demand declined. Housing stocks traded mixed midday, with Rocket Companies up nearly 1% and Radian down 0.5%. Builders’ sentiment remained weak, with the NAHB index at 36 in February.
February 18, 2026
IPG Photonics stock slips again after a 12% drop, even as Bernstein lifts its target

IPG Photonics stock slips again after a 12% drop, even as Bernstein lifts its target

IPG Photonics shares fell 1.4% to $133.01 in early Wednesday trading, extending a 12.38% drop from the previous session. Bernstein raised its price target to $162, citing a cyclical recovery. The company recently reported Q4 revenue up 17% year over year but flagged margin pressure from tariffs and inventory moves. Investors await Fed minutes and IPG’s March 2 investor conference.
February 18, 2026
ZIM stock price holds near $28 premarket as $35 Hapag-Lloyd bid meets strike risk

ZIM stock price holds near $28 premarket as $35 Hapag-Lloyd bid meets strike risk

ZIM shares rose 0.5% premarket to $27.99, staying about 20% below Hapag-Lloyd’s $35-per-share cash offer announced Tuesday. Workers at ZIM escalated strike action in Israel, halting activity at Haifa and Ashdod ports and raising deal risk. Hapag-Lloyd values ZIM at $4.2 billion and expects to close the deal by late 2026, pending regulatory and shareholder approval.
February 18, 2026
Gold price tumbles below $5,000 as U.S.-Iran talks ease safe-haven demand; Fed minutes, PCE in focus

Gold price tumbles below $5,000 as U.S.-Iran talks ease safe-haven demand; Fed minutes, PCE in focus

Gold dropped over 2% Tuesday, falling below $5,000 an ounce as the dollar strengthened and progress in U.S.-Iran nuclear talks eased safe-haven demand. Spot gold was last down 2.2% at $4,884.46, while U.S. April futures settled at $4,905.90. Gold-linked shares and Canada’s TSX gold index also fell sharply. Traders await the Fed’s January minutes Wednesday and U.S. inflation data Friday.
February 17, 2026
Palantir stock rises before the bell after 15-award sweep, with inflation data next in focus

Palantir stock rises before the bell after 15-award sweep, with inflation data next in focus

Palantir shares rose 1.8% to $131.41 in premarket trading Tuesday after the company won 15 categories in Dresner Advisory Services’ 2025 innovation awards. The move came as U.S. equity futures slipped and software stocks faced pressure tied to shifts in artificial intelligence. Palantir highlighted wins in data engineering, cloud computing, and “agentic AI.” Traders watched for signs customers are sticking with AI platforms amid industry disruption.
February 17, 2026
Grab (GRAB) stock slides in premarket as Wall Street reopens and investors weigh its 2026 outlook

Grab (GRAB) stock slides in premarket as Wall Street reopens and investors weigh its 2026 outlook

Grab shares fell about 3% to $4.13 in premarket trading Tuesday after the company last week forecast 2026 revenue below analyst estimates. The Southeast Asian platform posted its first full-year net profit and announced a $500 million buyback. Grab also agreed to acquire U.S. digital investing firm Stash Financial for up to $425 million, pending regulatory approval.
February 17, 2026
Transocean stock price steadies in premarket as RIG heads into earnings and Valaris deal scrutiny

Transocean stock price steadies in premarket as RIG heads into earnings and Valaris deal scrutiny

Transocean shares slipped 0.1% to $6.53 in early premarket trading Tuesday ahead of fourth-quarter results due Feb. 19. The company recently agreed to acquire Valaris in a $5.8 billion all-stock deal, creating a 73-rig fleet. Transocean also secured a $184 million contract extension in Norway. Investors await details on contracting momentum and the impact of oil price swings.
February 17, 2026
Plug Power stock in focus before the open as shareholders clear a big share-count change

Plug Power stock in focus before the open as shareholders clear a big share-count change

Plug Power shareholders approved a charter amendment doubling authorized common shares to 3 billion, according to a regulatory filing. Shares traded near $1.89 in premarket Tuesday after the Presidents Day holiday. The vote gives the company more flexibility to issue stock, a concern for investors watching potential dilution. A separate proposal to change voting rules did not pass.
February 17, 2026
Tesla stock treads water in premarket as Fed minutes loom after U.S. holiday

Tesla stock treads water in premarket as Fed minutes loom after U.S. holiday

Tesla shares traded flat in premarket Tuesday at $417 after a three-day U.S. market closure. Investors are awaiting Federal Reserve minutes and new economic data for signals on interest rates. Tesla’s capital spending plans and self-driving rollout remain key points for traders. China-made Model 3 and Model Y deliveries rose 9.3% in January from a year earlier.
February 17, 2026
1 37 38 39 40 41 46

Stock Market Today

  • Telix Pharmaceuticals Advances Connected Oncology Platform with Positive Phase 1 Glioblastoma Trial and Prostate Cancer Collaborations
    May 28, 2026, 5:56 PM EDT. Telix Pharmaceuticals (ASX:TLX) announced full patient enrolment in its Phase 1 IPAX-2 trial for TLX101-Tx targeting glioblastoma, with no dose-limiting toxicities observed at highest doses. The firm also signed letters of intent to explore prostate cancer collaborations involving PSMA PET imaging, supporting its strategy to develop a connected oncology platform combining brain cancer therapy and prostate cancer imaging-based treatments. While encouraging for TLX101-Tx safety, the update does not alter focus on late-stage trials like IPAX BrIGHT or ProstACT GLOBAL. Telix faces risks including heavy reinvestment and an ongoing SEC subpoena linked to its prostate therapeutics segment. Analysts project Telix's revenue and earnings could reach A$1.2 billion and A$111 million by 2029, implying 22.7% annual growth and significant earnings expansion. Current stock price reflects potential for nearly 93% upside, though uncertainties remain.